Muraki Y - Search Results

1

Discovery of novel 5-oxa-2,6-diazaspiro[3.4]oct-6-ene derivatives as potent, selective, and orally available somatostatin receptor subtype 5 (SSTR5) antagonists for treatment of type 2 diabetes mellitus.

Hirose H, Yamasaki T, Ogino M, Mizojiri R, Tamura-Okano Y, Yashiro H, Muraki Y, Nakano Y, Sugama J, Hata A, Iwasaki S, Watanabe M, Maekawa T, Kasai S. Hirose H, et al. Among authors: muraki y. Bioorg Med Chem. 2017 Aug 1;25(15):4175-4193. doi: 10.1016/j.bmc.2017.06.007. Epub 2017 Jun 9. Bioorg Med Chem. 2017. PMID: 28642028

2

Improvement of pulmonary arterial hypertension, inflammatory response, and epithelium injury by dual activation of cAMP/cGMP pathway in a rat model of monocrotaline-induced pulmonary hypertension.

Muraki Y, Naito T, Tohyama K, Shibata S, Kuniyeda K, Nio Y, Hazama M, Matsuo T. Muraki Y, et al. Biosci Biotechnol Biochem. 2019 Jun;83(6):1000-1010. doi: 10.1080/09168451.2019.1584520. Epub 2019 Mar 5. Biosci Biotechnol Biochem. 2019. PMID: 30835622

3

Elevation of liver endoplasmic reticulum stress in a modified choline-deficient l-amino acid-defined diet-fed non-alcoholic steatohepatitis mouse model.

Muraki Y, Makita Y, Yamasaki M, Amano Y, Matsuo T. Muraki Y, et al. Biochem Biophys Res Commun. 2017 May 6;486(3):632-638. doi: 10.1016/j.bbrc.2017.03.072. Epub 2017 Mar 18. Biochem Biophys Res Commun. 2017. PMID: 28322783

4

Fluorescent Imaging Analysis for Distribution of Fluorescent Dye Labeled- or Encapsulated-Liposome in Monocrotaline-Induced Pulmonary Hypertension Model Rat.

Muraki Y, Yamasaki M, Takeuchi H, Tohyama K, Sano N, Matsuo T. Muraki Y, et al. Chem Pharm Bull (Tokyo). 2018 Mar 1;66(3):270-276. doi: 10.1248/cpb.c17-00811. Epub 2018 Jan 6. Chem Pharm Bull (Tokyo). 2018. PMID: 29311495 Free article.

5

Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.

Nio Y, Tanaka M, Hirozane Y, Muraki Y, Okawara M, Hazama M, Matsuo T. Nio Y, et al. Among authors: muraki y. FASEB J. 2017 Dec;31(12):5307-5320. doi: 10.1096/fj.201700249R. Epub 2017 Aug 10. FASEB J. 2017. PMID: 28798156

In summary, we confirmed that piclamilast has significant antifibrotic effects in mdx mouse muscle and is a potential treatment for muscle fibrosis in DMD.-Nio, Y., Tanaka, M., Hirozane, Y., Muraki, Y., Okawara, M., Hazama, M., Matsuo, T. ...

In summary, we confirmed that piclamilast has significant antifibrotic effects in mdx mouse muscle and is a potential treatment for muscle f …

6

Phosphodiesterase 4 inhibition reduces lung fibrosis following targeted type II alveolar epithelial cell injury.

Sisson TH, Christensen PJ, Muraki Y, Dils AJ, Chibucos L, Subbotina N, Tohyama K, Horowitz JC, Matsuo T, Bailie M, Nikam S, Hazama M. Sisson TH, et al. Among authors: muraki y. Physiol Rep. 2018 Jun;6(12):e13753. doi: 10.14814/phy2.13753. Physiol Rep. 2018. PMID: 29952109 Free PMC article.

7

Fluorescence-labeled liposome accumulation in injured colon of a mouse model of T-cell transfer-mediated inflammatory bowel disease.

Yamasaki M, Muraki Y, Nishimoto Y, Murakawa Y, Matsuo T. Yamasaki M, et al. Among authors: muraki y. Biochem Biophys Res Commun. 2017 Dec 9;494(1-2):188-193. doi: 10.1016/j.bbrc.2017.10.058. Epub 2017 Oct 13. Biochem Biophys Res Commun. 2017. PMID: 29037813 Free article.

8

TNFR2 pathways are fully active in cancer regulatory T cells.

Okuzono Y, Muraki Y, Sato S. Okuzono Y, et al. Among authors: muraki y. Biosci Biotechnol Biochem. 2022 Feb 24;86(3):351-361. doi: 10.1093/bbb/zbab226. Biosci Biotechnol Biochem. 2022. PMID: 35015831

9

Correction to: The evaluation of lymph node cell proliferation response by liposomes loaded with major histocompatibility complex class II binding aquaporin 4 antigen peptide.

Muraki Y, Nishimoto Y, Yamasaki M, Miyakawa S, Sato S. Muraki Y, et al. Biosci Biotechnol Biochem. 2022 Feb 24;86(3):425. doi: 10.1093/bbb/zbab213. Biosci Biotechnol Biochem. 2022. PMID: 35136943 No abstract available.

10

The evaluation of lymph node cell proliferation response by liposomes loaded with major histocompatibility complex class II binding aquaporin 4 antigen peptide.

Muraki Y, Nishimoto Y, Yamasaki M, Miyakawa S, Sato S. Muraki Y, et al. Biosci Biotechnol Biochem. 2021 Feb 24;85(3):537-544. doi: 10.1093/bbb/zbaa084. Biosci Biotechnol Biochem. 2021. PMID: 33624776

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

297 results

Search Page